So based upon the recent ruling of Myriad Genetics (NASDAQ: MYGN) invalidation of certain patents covering the BRCA1 and BRCA2 genes, I was planning on levering the news as fodder for an all out April Fools’ post effort, likely to have been something along the lines of ‘10,000 Gene-based Patents Overturned, Biotechnology Industry Implodes’. A little voice inside kept me from tapping out that post, and instead rather than poking fun I’ve slid to the edge of my seat to see how this plays out in the Court of Appeals. I imagine that this case will amplify in media coverage over the coming weeks and months, it appears as though this evenings edition of 60 Minutes has kicked off said coverage.

If you are reading this post in an email or RSS feed click [HERE] to watch the video.